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Image-enhanced endoscopy refers to techniques of enhancing mucosa surface contrast with the ultimate aim of improving lesion detection and diagnosis.
It is vital to detect early gastric cancer as it may be possible to perform curative endoscopic resection. In this topic review, we summarize the options
available, such as the traditional dye-based chromoendoscopy, as well as the newer equipment-based techniques such as narrow-band imaging, ﬂexible
spectral imaging color enhancement, and i-scan. We further discuss in greater detail the technique of narrow-band imaging combined with magnifying
endoscopy, and how this has facilitated lesion characterization and diagnosis based on characteristic abnormal microvascular and microsurface features.
Other endoscopic imaging modalities such as autoﬂuorescence imaging and endoscopic microscopy are also brieﬂy discussed.
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Globally, gastric cancer is the fourth most common cancer in
men, the ﬁfth most common cancer in women, and the second
leading cause of death due to cancer. About 10% of annual cancer
deaths worldwide are attributed to gastric cancer, which means
that gastric cancer has a high fatality to case ratio of about 70%.1 The
highest incidence rates for gastric cancer occur in East Asia (China,
Mongolia, Korea, and Japan).2,3 Gastric cancer is histologically
divided into two types in the Lauren classiﬁcation: intestinal (with
intercellular junctions) and diffuse (without intercellular junc-
tions).4 More than 90% of gastric cancers are intestinal-type
adenocarcinoma, which is believed to be preceded by a “precan-
cerous cascade,” progressing in a sequential manner from chronic
gastritis, atrophic gastritis, intestinal metaplasia, and adenoma to
early gastric cancer (EGC).5
The overall prognosis of gastric cancer is dismal; the average 5-
year survival rate is less than 20% and EGC are often clinically silent.
However, if the cancer is detected and endoscopically resected
prior to invasion into the muscularis propria occurs, the 5-year
survival rate can reach 90%.6 EGC, a term deﬁned by Japanese re-
searchers in 1962, is meant to denote the curable phase of the
disease when cancer cells are conﬁned within the mucosal or
submucosal layer (T1 cancer) regardless of the presence of lymph
node metastasis.7 Endoscopic resection using the endoscopic
mucosal resection (EMR) technique or endoscopic submucosal
dissection (ESD) is potentially curative for the patient if there is no
nodal metastasis, and can avoid the morbidity associated withDepartment of Gastroenterology and Hepatology, Changi General Hospital, Singapore
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differentiated adenocarcinoma, is less than 2 cm, has no ulceration,
and has no lymphovascular involvement.8 Gotoda et al9 reviewed
surgical pathological data and found that differentiated cancers less
than 3 cm in diameter and undifferentiated cancers less than 2 cm
in diameter had negligible nodal metastasis. Submucosal cancers
that were differentiated, were less than 3 cm in diameter, and
invaded less than 500 mm into the submucosal were also free of
nodal metastasis.9 Another large study involving 5265 patients
found similar results and proposed that endoscopic resection
should be considered for undifferentiated intramucosal cancers,
which are less than 2 cm in diameter and has no ulcerative ﬁndings
or lymphovascular involvement, as the risk of lymph node metas-
tasis was negligible.10 This led to expanded criteria for endoscopic
resection. En bloc resection is crucial for accurate histopathological
assessment and, in the context of lesions larger than 2 cm or in the
presence of ﬁbrosis or ulceration, ESD rather than EMR would be
the technique of choice.
Thus, the early detection of EGC is important. However, the
sensitivity of conventional white light imaging (C-WLI) in detecting
EGC had been reported to range only from 77% to 84%.11 Image-
enhanced endoscopy (IEE) involves the use of dyes, optical
methods (by manipulation of the light source), and electronic
methods (by manipulation of captured light), to increase the
contrast of surface structure, and thus improve visualization and
diagnostic accuracy. There are three different commercially avail-
able systems for equipment-based IEE: (1) narrow-band imaging
(NBI; Olympus Corporation, Tokyo, Japan); (2) ﬂexible spectralSimei Street 3, 529889, Singapore.
vier. Open access under CC BY-NC-ND license.
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scan (Pentax, Tokyo, Japan). IEE can be combined with magnifying
endoscopy to further characterize focal lesions. This review will
focus on the utility of IEE techniques and brieﬂy discuss other
endoscopic imaging modalities such as autoﬂuorescence imaging
(AFI) and endoscopic microscopy.
Chromoendoscopy
Chromoendoscopy involves the spraying of a dye onto the
gastric mucosa after a complete inspection with C-WLI to highlight
any subtle mucosal irregularities that could have been missed.
Absorptive dye such as methylene blue is actively absorbed by in-
testinal epithelium, therefore highlighting the area of intestinal
metaplasia. Contrast dyes such as indigo carmine have no cellular
staining; the dye pools in the crevices of the lesion and accentuates
its border and surface topography (Fig. 1A and B). This signiﬁcantly
helps detect nonpolypoid EGC. In some centers in Japan, diluted
indigo carmine is routinely sprayed throughout the stomach after a
complete screening examination.12
NBI
NBI is an endoscopic technique that uses narrow bandwidth
ﬁlters in the red–green–blue sequential illumination system. The
ﬁlters are enabled or disabled during endoscopy by pushing a
button to limit the wavelengths of light to that of blue (400–
430 nm) and green (430–460 nm) via the mechanical insertion of a
narrow band ﬁlter in front of the xenon arc lamp. Blue and green
light penetrate less deeply into the gastric mucosa and are prefer-
entially absorbed by hemoglobin so that vessels appear dark
colored. On the endoscopy monitor, the signals obtained from the
blue and green ﬁlters are combined to form an image that high-
lights the vasculature on the superﬁcial mucosa.13–15 However,
owing to the weak light intensity and the large size of the gastric
lumen, the images obtained by NBI alone tend to be very dark,
which signiﬁcantly limits its utility for endoscopic screening and
surveillance of gastric lesions.16 Newer generation NBI processors
(290 and 190 series) with higher light intensities have been
developed and may potentially improve detection rates.17
FICE and i-scan
FICE is a spectral estimation technique that enhances the
contrast of mucosal surfaces. Thewhite-light image captured by the
endoscope is sent to a spectral estimationmatrix processing circuit.Fig. 1. Image enhanced endoscopy appearance of gastric adenoma. (A) White light endoscop
accentuated by indigo carmine chromoendoscopy. (C) Narrow band magnifying image of gFICE processes the image into spectral images composed from a
single wavelength and then displays them in real time. Unlike NBI,
FICE is software driven and does not use optical ﬁlters. The wave-
lengths used with FICE are associated with laminar structures and
blood ﬂow in the gastrointestinal mucosa altered by inﬂammation
or neoplasm, which acts as a scattering element and interferes with
the reﬂectance spectrum. Like NBI, the operator can switch be-
tween thewhite-light image and the FICE image by a simple push of
a button on the endoscope, and this technology can be coupled
with optical or digital magniﬁcation.18 The better contrast between
the malignant lesion and the surrounding normal mucosa signiﬁ-
cantly helps in accurately diagnosing the lateral extent of gastric
cancer compared to C-WLI (Fig. 1C, Fig. 2A and B).19 i-Scan is
another digital contrast method applying postprocessing algo-
rithms to white light images to enhance the image contrast.17 There
are three modes: surface enhancement mode, contrast enhance-
ment mode, and tone enhancement mode. Similar to FICE, i-scan
uses software to improve the contrast of gastric lesions against the
normal mucosa (Fig. 3A and B). In contrast to NBI, for which there
are abundant data concerning its utility in the diagnosis of EGC, the
published data concerning the performance characteristics of FICE
and i-scan in the diagnosis of EGC are limited.
Magnifying endoscopy
Standard high deﬁnition (HD) endoscopy can enlarge an image
up to 30 times, whereas high-magniﬁcation endoscopy (ME) can
enlarge an image up to 100 times. In terms of image resolution,
optical zoom, in which a zoom lens is connected to the endoscope
tip, is superior to digital zoom or electronic magniﬁcation.20 Digital
zoom relies on signal processing to enlarge images obtained from
the charged-couple device (CCD), and this tends to decrease image
quality. To optimize ME, adequate preparations are required. There
must be optimal cleansing of the mucosal surface, such as with
diluted 0.04% simethicone solution and mucolytics, to remove
mucus and foam. HD white light endoscopy should be used. A soft
black hood is essential; this should be mounted on the endoscopy
tip to allow the endoscopist to consistently ﬁx the mucosa at about
2–3 mm from the lens to allowmaximal magniﬁcation and optimal
image resolution. The entire mucosal surface should be carefully
surveyed without magniﬁcation ﬁrst; when a suspicious lesion is
detected, the lesion should be inspected selectively by magniﬁca-
tion in order to visualize the ﬁne patterns and capillaries on the
mucosa. ME, when combined with IEE, can clarify the microvas-
cular and microsurface features and facilitate lesion characteriza-
tion and diagnosis.y image of gastric adenoma with 0-IIa morphology. (B) Margins of gastric adenoma are
astric adenoma with regular microvascular and microsurface patterns.
Fig. 2. Image enhanced endoscopy appearance of early gastric cancer. (A) White light endoscopy image of early gastric cancer. (B) Enhancement of the mucosal surface structure of
early gastric cancer by ﬂexible spectral imaging color enhancement (FICE) (A and B are courtesy of Fujiﬁlm, Tokyo, Japan.).
Fig. 3. Image enhanced endoscopy appearance of early gastric cancer. (A) White light endoscopy image of early gastric cancer. (B) Enhancement of the mucosal surface structure of
early gastric cancer by i-scan (A and B are courtesy of Dr. Joo Young Cho and Dr Won Young Cho, Soon Chun Hyang University Hospital Seoul Korea.).
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The potential of NBI for diagnosis of EGC is maximized when
combined with ME.21 The microvascular architecture and the
microsurface structure can then be clearly visualized to facilitate
detection of changes of metaplasia, dysplasia, or cancer and to
detect an important line of demarcation from the surrounding
normal mucosa (Figs. 1C, 4A, and 4B).22 The Paris classiﬁcation for
superﬁcial gastrointestinal neoplasia divides the lesion into threeFig. 4. Image enhanced endoscopy appearance of early gastric cancer. (A) White light endo
cancer showed irregular microvascular and microsurface patterns.main categories: superﬁcial elevated (0-IIa) type, superﬁcial ﬂat (0-
IIb) type, and superﬁcial depressed (0-IIc) type.23 For the 0-IIb and
0-IIc types of gastric neoplasia, NBI combined with ME (NBI-ME)
has been shown to be useful for distinguishing between benign and
malignant lesions based on the abnormal microvascular pattern in
malignant lesions.24,25
Using NBI-ME, endoscopists have been able to discern carcino-
matous gastric lesions from benign gastric lesions. Many classiﬁ-
cation systems have been introduced to describe these NBI-MEscopy image of early gastric cancer. (B) Narrow band magnifying image of early gastric
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classiﬁcation introduced by Yao and colleagues.26 “V” stands for the
vascular pattern of microvessels. The regular pattern consisted of
mucosal capillaries with uniform thickness and a symmetrical
arrangement of closed-loop (polygonal) or open-loop shapes. The
irregular pattern consisted of vessels that differed in shape and size
and was asymmetrically distributed over the lesion. “S” stands for
surface microstructure such as crypt epithelium and the presence
of white opaque substance (WOS). In a regular surface pattern, the
crypt epithelium has a constant width and a uniform structure,
which may be round, oval, tubular, curved, or papillary. WhenWOS
is present, it tends to be arranged in a well-organized and sym-
metrical reticular, maze-like, or speckled pattern. In irregular sur-
face patterns, the crypt epithelium has variable width and the
distribution and arrangements are irregular and asymmetrical. The
WOS, if present, tends to also be in an irregular reticular or speckled
pattern of asymmetrical distribution.26 WOS is attributable to lipid
deposition within the neoplastic epithelium.27,28
The characteristic NBI-ME ﬁndings of EGC include an irregular
microvascular pattern with a demarcation line and/or an irregular
microsurface pattern with a demarcation line. In a study by Yao
et al,26 97% (97/100) of EGC fulﬁlled either one or both of these
criteria. The three cases that did not meet the VS classiﬁcation
criteria were poorly differentiated carcinomas that were found on
histological examination to have invaded sparsely and diffusely
into the lamina propria beneath the surface epithelium. This was
the reason why these three lesions did not have obvious distur-
bance in the microvascular or microsurface pattern and had no
distinct demarcation line from the surrounding mucosa. Yao et al29
also reported that WOS was more frequently seen in gastric ade-
nomas compared to gastric carcinomas (78% vs. 43%, P < 0.05), and
the pattern of WOS was of a regular pattern in all adenomas, but of
an irregular pattern in 83% of the carcinomas (P < 0.0001). This
showed that although WOS obscured the visualization of micro-
vascular pattern, it could also be useful as an optical sign to help
investigators determine if a lesion is malignant.
Kaise et al30 suggested another way of detecting cancerous le-
sions with NBI-ME by focusing on speciﬁc features that are more
unique to malignancy: the disappearance of ﬁne mucosal structure,
the dilatation of microvasculature, and the heterogeneity of the
surface pattern. In the evaluation of 0-IIb or 0-IIc lesions based on
this diagnostic triad, NBI-ME achieved a diagnostic sensitivity of
92.9% and a speciﬁcity of 94.7% comparedwithWLI, which only had
a diagnostic sensitivity of 42.9% and a speciﬁcity of 61.0%.30
Nakayoshi et al31 conducted a prospective study to measure the
correlation between diagnosis made based on magnifying NBI
ﬁndings and the actual histology result of 0-IIc EGC lesions. They
broadly classiﬁed the microvascular network into three general
patterns: A, ﬁne network pattern (FNP); B, corkscrew pattern (CSP);
and C, unclassiﬁed pattern.31 They compared the microvascular
pattern trends between undifferentiated adenocarcinoma lesions
and differentiated adenocarcinoma lesions to see if NBI-ME was
capable of predicting the histological characteristics of gastric
cancer lesions. They found that differentiated adenocarcinomas
tend to have FNP (66.1% vs. 3.7%), whereas undifferentiated ade-
nocarcinomas tend to have CSP (85.7% vs. 3.6%, P ¼ 0.0011). How-
ever, 30.3% of the differentiated adenocarcinomas and 10.7% of the
undifferentiated adenocarcinomas had “unclassiﬁed” microvas-
cular pattern on NBI-ME.
Yokoyamaet al32 introduced twoadditional categories to describe
the abnormal microvascular pattern and irregularity of superﬁcial
glandular structure of EGC; intralobular loop pattern 1 (ILL-1) and
intralobular loop pattern 2 (ILL-2). In ILL-1, there is avillous glandular
structure with loop-like microvessels in it. In ILL-2, the villous glan-
dular structure shows the areas of destruction and the microvesselsdo not show a complete “loop”. These four categories follow a
gradientof increasingdistortion to themucosal surfacedfromFNP, to
ILL-1, to ILL-2, andﬁnally to the highly irregular CSP. Yokoyamaet al32
didnot limit this studytoonly0-IIc EGC lesions;0-IIa and0-IIb lesions
were also included. In determining the pattern category, the pre-
dominant visible patternwas used. They were able to classify all 223
differentiated adenocarcinomas and 54 undifferentiated adenocar-
cinomas. There were no “unclassiﬁed” lesions, but they had stated
that cases with an ulcer with white ﬁbrin were excluded from the
study analysis. Their results showed that differentiated adenocarci-
nomasmainly showed ILL-1 (133/223 lesions) and very little showed
CSP (1/223 lesions). By contrast, undifferentiated lesions had pre-
dominantly CSP (20/34 lesions) and ILL-2 lesions (14/54 lesions).
Overall, 41.2% of the undifferentiated cancers had ILL-2, whereas
24.2% of the differentiated cancers had ILL-2.
NBI-ME has been proven to be superior to C-WLI, ME, and
chromoendoscopy in gastric cancer detection and the determina-
tion of tumor margins. With C-WLI, red discoloration, mucosal ul-
ceration, and depressed lesions are associated with higher
likelihood of carcinoma.33 Maki et al34 compared C-WLI with NBI-
ME and found that NBI-ME had signiﬁcantly higher sensitivity
(95% vs. 64%) and accuracy (92% vs. 74%) in detecting EGC. However,
in elevated lesions with red discoloration, the speciﬁcity of NBI-ME
and C-WLI was comparable (88% vs. 94%). Tsuji et al35 showed that
NBI-ME was signiﬁcantly better than C-WLI in distinguishing ade-
nomas from carcinomas. In their retrospective study, 37 cases were
selected that were diagnosed as gastric adenomas based on C-WLI
ﬁndings and pretreatment forceps biopsy. The presence of irregular
microvascular or microsurface pattern with demarcation line on
NBI-ME was signiﬁcantly correlated with the ﬁnal pathological
diagnosis of carcinoma (odds ratio 13.68, 95% conﬁdence interval
5.69–32.88, P < 0.001.). Kato et al36 compared the yield of C-WLI
andNBI-ME in patients who underwent endoscopic surveillance for
synchronous or metachronous gastric cancer. The sensitivity and
speciﬁcity for ME-NBI for diagnosis of gastric cancer (92.9% and
94.7%, respectively) were signiﬁcantly better than those for CWLI
(42.9% and 61.0%, respectively). A single-center study ﬁrst showed
that NBI-ME had a better diagnostic accuracy in differential diag-
nosis of gastric small depressive lesions compared to ME; the
diagnostic accuracy for gastric cancer in NBI-ME was 79% (45/57
lesions) versus 44% (25/57 lesions) in ME.37 This was later sub-
stantiated by a multicenter, prospective, randomized, controlled
trial that compared C-WLI to NBI-ME in patients with undiagnosed
depressed gastric lesions less than 10 mm in diameter. The diag-
nostic accuracy of NBI-ME was signiﬁcantly better than that of C-
WLI (90.4% vs. 64.8%, P < 0.001), whereas the diagnostic sensitivity
of NBI-ME was higher but not as statistically signiﬁcant (60.0% vs.
40.0%, P ¼ 0.34). However, combining C-WLI with NBI-ME signiﬁ-
cantly increased both diagnostic accuracy (from 64.8% to 96.6%,
P ¼ 0.001) and diagnostic sensitivity (from 40.0% to 95.0%,
P ¼ 0.001).38 The usefulness and limitations of NBI-ME when
chromoendoscopy was unsuccessful for determining the horizontal
extent of EGC was examined in a case series of 350 consecutive EGC
resected en bloc by ESD. The proportion of cancers showing unclear
margins by chromoendoscopy was 18.9% (66/350). Of these, 62/66
were examined by NBI-ME, and entire margins were successfully
delineated in 72.6% (45/62). This showed that NBI-ME was an
excellent modality for identifying the entire margin of EGC when
chromoendoscopy was unsuccessful. The frequency of undifferen-
tiated EGC was signiﬁcantly higher in cancers with unsuccessful
delineation by NBI-ME than in cancers with successful delineation
by NBI-ME.39 A randomized study of NBI-ME versus indigo carmine
chromoendoscopy showed that the accuracy for determination of
tumor margins was signiﬁcantly higher in the NBI-ME group (97.4%
vs. 77.8%, P ¼ 0.009).40
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“ﬁrst-line” inspection during endoscopy prior to switching to ME
for a closer inspection of lesions, and then switching to NBI-ME for
a better visualization of microvasculature and microsurface
pattern, and also for ascertainment of tumormargins, should indigo
carmine chromoendoscopy be inadequate. However, there are
limitations for NBI-ME in evaluating tumor depth. Nagahama et al39
found that NBI-ME failed to accurately delineate the margins of the
lateral extent in 27.4% (17/63) of cancers, and subanalysis revealed
that undifferentiated cancers were signiﬁcantly higher among the
cases of failed delineation. This was because undifferentiated can-
cers tend to inﬁltrate into the lamina propria without disturbing
the surface microvascular and microsurface patterns. In 2010, an
Asian Paciﬁc consensus conference on NBI diagnosis of upper
gastrointestinal cancer stated that NBI-ME was not useful for
evaluation of tumor depth of EGC because of its inability to visu-
alize submucosal invasion.16AFI
AFI detects the natural tissue ﬂuorescence emitted by endoge-
nous molecules (ﬂuorophores) such as collagen, ﬂavin, adenine
dinucleotide, nicotinamide, and porphyrins. When these ﬂuo-
rophores are excited by a short-wavelength light source, they emit
light of longer wavelengths. Normal tissue and neoplastic tissue
have different ﬂuorescence emissions. In AFI mode, a rotating color
ﬁlter wheel in front of the xenon light source sequentially generates
blue and green light to illuminate the tissues. Another interference
ﬁlter in front of the AFI CCD selectively allows the tissue auto-
ﬂuorescence colors (of 500–630 nm wavelengths) and green light
to ﬁlter through. The video processor then integrates these colors
into a pseudocolor image on the screen.41
However, the role of AFI in detecting gastric neoplasia is limited
by the inconsistent autoﬂuorescence patterns in the stomach and
the poor speciﬁcity. Elevated EGC lesions tend to appear purple
(Fig. 5) as the collagen in the submucosal layer (which emits a green
autoﬂuorescence) may be obscured by the tumor. Depressed EGC
may appear green instead. For the background color of normal
mucosa, the gastric body and pylorus are normally green, whereas
the gastric fundic mucosa is normally purple. In addition, mucosalFig. 5. Autoﬂuorescence image of early gastric cancer.
F
D
Fthickening or edema caused by ulceration or scarring will also look
purple. Consequently, AFI can lead to a large number of false pos-
itive ﬁndings.42 The sensitivity levels of AFI and C-WLI were com-
parable, and the speciﬁcity of AFI was actually lower than that of C-
WLI because of higher false positives.43
Trimodal imaging video endoscopy
In trimodal imaging video endoscopy, two separate mono-
chromatic CCD are located at the tip of the endoscope for image
capture; one CCD is dedicated to C-WLI and NBI, whereas the other
CCD is for AFI. Switching between the imaging modes just requires
pushing a button on the handle of the endoscope. This allows C-
WLI, AFI, and NBI-ME to be sequentially performed in the same
patient in one endoscopy session. In a prospective study conducted
by Kato et al,44 it was found that the addition of AFI and NBI-ME to
C-WLI increased the detection rate of gastric neoplasia by 12.8%.
The three modes complemented each other; NBI-ME improved the
diagnostic accuracy by reducing the false positive ﬁndings associ-
ated with AFI and C-WLI, whereas AFI increased the detection of
abnormal mucosa compared to C-WLI.
Microscopic endoscopy
The term “microscopic” endoscopy suggests that endoscopists
may be able to perform real-time “live” histology evaluation by
using technology that enlarges the image by 500–1000 times. The
optical method would be the combination of a CCD with a micro-
scopy optical system such that the images aremagniﬁed to the point
where nuclei and tissue architecture may be discernible. “Endocy-
toscopy” is a good term to describe thismethod, inwhich images are
magniﬁed up to 1100 times and the nuclei could be stained with
dyes such as methylene blue to highlight atypical nuclear changes.
The confocalmethod, otherwise known as confocal laser endoscopy
(CLE) can magnify the image to 1000 times and requires the intra-
venous administration or direct spraying of ﬂuorescent dye. It uses
an argon ion laser light with a scanning depth of 0 (epithelium) to
250 mm (lamina propria), and the reﬂected light is then refocused
via a pinhole, which markedly increases the image resolution.45 For
CLE, two systems are currently available. One uses a miniaturized
confocal scanner integrated into the tip of an otherwise conven-
tional endoscope (endoscope integrated CLE; Pentax, Tokyo, Japan).ig. 6. Confocal image of gastric dysplasia (Courtesy of Dr. Douglas Pleskow, Beth Israel
eaconess Medical Center, Boston, MA, USA, and Mauna Kea-Technology, Paris,
rance.).
Table 1 Summary of Image Enhanced Endoscopy Techniques
Indigo carmine
chromoendoscopy
NBI i-Scan FICE
Overview of technique The dye pools in the crevices of
a lesion, accentuating its
borders and surface
topography.
A mechanical optical ﬁlter limits
incident wavelengths to blue and green
light, enhancing contrast between
superﬁcial vessels and mucosa.
It is a digital contrast method
that applies postprocessing
algorithms to white light
images to enhance the image
contrast.
It is a digital contrast method
based on spectral estimation
techniques to enhance the
image contrast.
Published comparative
data for early gastric
cancer diagnosis
Not available NBI-ME vs. C-WLI
Maki*
Sensitivity: 95% vs. 65%
Speciﬁcity: 88% vs. 94% (not signiﬁcant)
Accuracy: 92% vs. 74%
Katoy
Sensitivity: 92.9% vs. 42.9%
Speciﬁcity: 94.7% vs. 61%
CWLI þ NBI-ME vs. NBI-ME vs. CWLI
Ezoez
Sensitivity: 95% vs. 60% vs. 40%
Speciﬁcity: 96.8% vs. 94.3% vs. 67.9%
Accuracy: 96.6% vs. 90.4% vs. 64.8%
Comparative studies against
other imaging modalities not
available.
Comparative studies against
other imaging modalities not
available.
Qualitative assessment Can supplement C-WLI by
highlighting any subtle mucosal
irregularities that could have
beenmissed. It is routinely used
to demarcate cancer margins
prior to endoscopic submucosal
dissection. It may be combined
with optical magniﬁcation to
visualize the microsurface
pattern. However microvessels
will not be as well visualized as
by NBI. Dye-spray can be messy
and laborious.
Able to provide enhanced contrast of
mucosal surface. Excellent for
demonstrating the morphology of ﬁne
microvessels when combined with
optical magniﬁcation. The endoscopic
view was dark with the older
generation of NBI systems thus limiting
its role in lesion detection as compared
to lesion characterization but
illumination is now brighter with the
new generation NBI systems.
It yields bright and high
contrast images of lesions.
It yields bright and high
contrast images of lesions.
* Retrospective comparative study.
y Prospective single-center comparative study.
z Prospective multicenter randomized study.
AFI, autoﬂuorescence; C-WLI, conventional white light imaging; FICE, ﬂexible spectral imaging color enhancement; NBI, narrow band imaging; NBI-ME, NBI combined with
ME.
Gastrointestinal Intervention 2014 3(1), 1–76The other system in clinical use is probe-based CLE (Mauna Kea-
Technology, Paris, France) and has the advantage of compatibility
with most conventional endoscopes (Fig. 6). These microscopic
endoscopy technologies are currently not routinely used in clinical
practice, being more of research tools. In addition to the cost of
obtaining the equipment, there is also a steep learning curve to
using this technology, and it signiﬁcantly lengthens the procedure
time because of its limited ﬁeld of view.
Conclusion
HD C-WLI remains the main imaging modality for detection of
focal gastric lesions. However, IEE is an important tool for the diag-
nosis and characterization of EGC. The relativemerits, and the results
of key published data of the different techniques of IEE are summa-
rized in Table 1. In particular, there is substantial evidence that the
combination of C-WLI and NBI-ME is superior to C-WLI alone or
chromoendoscopy in terms of diagnostic accuracy and delineating
tumor margins. In the era when endoscopic resection guidelines are
beingexpanded, IEE shouldbecomeastandardofpracticeas theearly
detection of gastric cancer allows curative treatment.
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